A novel jackknife-based approach to covariate adjustment through generalized linear models (GLMs), which is term as JAckknife Score-based Adjustment (JASA), together with its calibrated version JASACal, which can adjust for a much greater number of covariates than existing benchmarks.
Abstract
Adjusting for baseline covariates has become standard practice in analyzing randomized clinical trials. In the low-dimensional setting, it is well understood that covariate adjustment through a parametric working model can sometimes be more efficient than the unadjusted difference-in-mean estimator. However, when the number of adjusted covariates is large relative to the sample size $n$, a na\"{i}ve adjustment may introduce excessive bias, leading to invalid statistical inference. The current literature that tries to resolve this issue is either limited to linear working models or relies on sample splitting, which may raise concerns about the replicability of RCT analyses. In this paper, we devise a novel jackknife-based approach to covariate adjustment through generalized linear models (GLMs), which we term as JAckknife Score-based Adjustment (JASA), together with its calibrated version JASACal. By employing a nuanced jackknife strategy, JASA and JASACal avoid sample splitting and make full use of the data, while ensuring that the bias of JASA or JASACal is still negligible even when the number of adjusted covariates is large compared to $n$. JASA also encompasses state-of-the-art adjusted estimators through linear working models as a special case. Through extensive simulation experiments and a real data analysis, we demonstrate that JASA or JASACal can adjust for a much greater number of covariates than existing benchmarks. These empirical results also shed some new light on practical guidance for covariate adjustment with GLMs. Both JASA and JASACal have been incorporated into our R package HOIFCar available from CRAN. The package HOIFCar is developed to serve as a user-friendly option for covariate adjustment in RCTs, in particular when practitioners hope to adjust for a large number of covariates.
A new inference method for conducting multiple-treatment comparisons involving endpoints within the generalized linear model (GLM) framework under covariate-adaptive randomization (CAR) that can effectively control Type I error while potentially improving power.
Covariate adjustment can improve precision in estimating treatment effects in clinical trials, and regulatory guidance increasingly encourages its implementation. Despite its benefits, covariate adjustment can require advanced statistical techniques or tailored approaches for different estimands, which can deter its us...
Kayla Irish, Jose R. Zubizarreta, Alex Luedtke· 0 citations
Background/Aims: Adjustment for prognostic baseline covariates can improve precision in randomized trials. Previous work has shown that jointly modeling primary and secondary endpoints can yield additional precision by borrowing information across endpoints. We investigated whether these approaches can be combined to a...
Jack M. Wolf, Joseph S. Koopmeiners, David M. Vock· 0 citations
The log-rank test and Kaplan--Meier plot are standard tools for analyzing time-to-event data in randomized clinical trials, yet neither provides a summary of the magnitude of the treatment effect. Practitioners typically fill this gap by reporting a hazard ratio from a Cox proportional-hazards model or an acceleration...
Lucy D'Agostino McGowan, Joseph Rigdon, Xin-Ran Li et al.· 0 citations
The proposed framework provides a flexible and interpretable approach to treatment effect inference under distributional heterogeneity and achieves a favorable balance between robustness and statistical efficiency.
K. Maruo, Ryota Ishii, Yusuke Yamaguchi et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.